Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05A PARATHYROID HORMONES AND ANALOGUES
H05AA Parathyroid hormones and analogues
H05AA05 Palopegteriparatide
D12395 Palopegteriparatide (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Metabolic Bone Disease Agents
Calcium Regulating Hormones
Palopegteriparatide
D12395 Palopegteriparatide (JAN/USAN/INN)
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and parathyroid hormone-related protein analog
D12395 Palopegteriparatide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Parathyroid hormone
PTH1R
D12395 Palopegteriparatide (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12395
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12395
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12395
